bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference September 22, 2026
bioAffinity Technologies Announces Grant of Hong Kong Patent for Company’s CyPath® Lung Noninvasive Lung Cancer Diagnostic September 17, 2026
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference September 3, 2026
